The Intel Healthcare Innovation Barometer conducted by Penn Schoen Berland reveals that many people are willing to anonymously share their medical data to lower the cost of healthcare. With this information, drug development can be fine-tuned enough to meet the needs of the individuals and not just the average person. A massive amount of computing power is needed to analyze the influx of data and
change how we understand disease. With improvements in computing power, we may reduce the time required to "crunch" the data from years to hours.